| Chemoradiation and Panitumumab for Esophageal Cancer (NCT01077999) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2010-01-01 |
| Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology (NCT03462524) | St. James's Hospital, Ireland | 2010-01-01 |
| A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma (NCT01051934) | National Cancer Institute (NCI) | 2009-12-29 |
| Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer (NCT00892242) | Washington University School of Medicine | 2009-12-01 |
| Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRI (NCT01020630) | PD Dr Markus Möhler | 2009-11-01 |
| Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks (NCT01037049) | Royal Marsden NHS Foundation Trust | 2009-10-16 |
| BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation (NCT00949650) | Boehringer Ingelheim | 2009-08-14 |
| Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma (NCT00917384) | Eli Lilly and Company | 2009-08-01 |
| RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe (NCT00688753) | Novartis Pharmaceuticals | 2009-07-01 |
| Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies (NCT00923026) | National Cancer Institute (NCI) | 2009-06-15 |
| Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer (NCT00911118) | Memorial Sloan Kettering Cancer Center | 2009-05-26 |
| TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer (NCT00940069) | Hunan Province Tumor Hospital | 2009-03-01 |
| A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer (NCT01249352) | Eurofarma Laboratorios S.A. | 2009-01-01 |
| Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer (NCT00719264) | Novartis Pharmaceuticals | 2008-11-12 |
| Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy (NCT00795184) | Mauna Kea Technologies | 2008-11-01 |
| Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach (NCT00800969) | University of Zurich | 2008-10-01 |
| Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas (NCT00918853) | Institut Paoli-Calmettes | 2008-08-01 |
| Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO) (NCT00661830) | PD Dr Markus Möhler | 2008-05-01 |
| A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer (NCT00672009) | Cedars-Sinai Medical Center | 2008-04-01 |
| A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. (NCT00600821) | Pfizer | 2008-04-01 |
| Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) (NCT00632203) | Merck Sharp & Dohme LLC | 2008-03-04 |
| The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy (NCT00751543) | National Taiwan University Hospital | 2008-01-01 |
| A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer (NCT00548548) | Genentech, Inc. | 2007-09-01 |
| Low Rectal Cancer Study (MERCURY II) (NCT02005965) | Royal Marsden NHS Foundation Trust | 2007-08-13 |
| Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma (NCT00495924) | KU Leuven | 2006-10-01 |
| Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic Cancer (NCT00395252) | Carmen Schade-Brittinger | 2006-10-01 |
| Identification of Key Blood Molecular Markers for Immunotherapy (NCT00507702) | Stanford University | 2006-07-06 |
| Symptom Assessment With Patient Surveys (NCT01135823) | Stanford University | 2006-07-01 |
| Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC (NCT00321048) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-06-01 |
| Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer (NCT00368329) | Stanford University | 2006-06-01 |
| Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas (NCT00443196) | Pierian Biosciences | 2006-03-01 |
| Effect of Vitamin D and Calcium on Genes in the Colon (NCT00298545) | Rockefeller University | 2005-11-01 |
| Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus (NCT00259987) | GlaxoSmithKline | 2005-11-01 |
| EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas (NCT00377936) | MediGene | 2005-09-01 |
| Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer (NCT00129844) | Pharmacyclics LLC. | 2005-09-01 |
| Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination (NCT00507091) | Genzyme, a Sanofi Company | 2005-08-01 |
| Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary (NCT00201734) | Ohio State University Comprehensive Cancer Center | 2005-06-01 |
| Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors (NCT00106353) | Pfizer | 2005-03-01 |
| Use of Tracking Devices to Locate Abnormalities During Invasive Procedures (NCT00102544) | National Institutes of Health Clinical Center (CC) | 2005-02-23 |
| Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma (NCT00191503) | Eli Lilly and Company | 2005-01-01 |
| ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer (NCT00102700) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2005-01-01 |
| Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung (NCT00137839) | Pasi A. Janne, MD, PhD | 2004-11-01 |
| Trial of Curcumin in Advanced Pancreatic Cancer (NCT00094445) | M.D. Anderson Cancer Center | 2004-11-01 |
| PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer (NCT00088413) | National Cancer Institute (NCI) | 2004-07-21 |
| Combined Thoracoscopic and Laparoscopic Esophagectomy vs. Hand-assisted Transhiatal Esophagectomy: A Prospective Trial. (NCT00247936) | University of California, Irvine | 2004-05-01 |
| Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer (NCT00054873) | Chiron Corporation | 2003-11-01 |
| Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) (NCT00127036) | H. Lee Moffitt Cancer Center and Research Institute | 2003-10-01 |
| Evaluation of Stereotactic Radiosurgery For Liver Malignancies (NCT00230347) | Stanford University | 2003-10-01 |
| Study of MDX-010 in Stage IV Breast Cancer (NCT00083278) | Bristol-Myers Squibb | 2003-05-01 |
| Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas (NCT00051675) | XOMA (US) LLC | 2002-07-01 |
| Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer (NCT00201331) | National Health Research Institutes, Taiwan | 2002-04-01 |
| A Long Term Safety Study With Atrasentan (NCT00127478) | Abbott | 2001-07-01 |
| Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma (NCT00201838) | Ohio State University Comprehensive Cancer Center | 2001-07-01 |
| Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer (NCT00140075) | Pfizer | 2000-11-01 |
| Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Adenocarcinoma of the Breast (NCT02204046) | Boehringer Ingelheim | 2000-01-01 |
| Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan (NCT00183859) | University of Southern California | 1999-09-01 |
| Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas (NCT00116389) | Point Therapeutics | |